scPharmaceuticals (SCPH) Environmental, Social & Governance (ESG) Data

Employees

Data from SEC filings

Employee count

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Climate Environment Environmental Lifecycle Materials Nature Offset Package Packaging Pandemic Resiliency Solar Toxic Waste Water Access Access and affordability African American Asian Benefits Black Collective Bargaining Community Culture Customer Cyber Cyber Security Cybersecurity Data Security Death Demographic Disability Diversity Diversity and Inclusion Drug Pricing Employee Employee Retention Engagement Ethnic Ethnicity Gender Health and Safety Health Care Healthcare Hire Hiring Hispanic Human Capital Human Resources Incident Injuries Injury Latinx LGBTQ Minority Privacy Product Safety Recall Recruit Recruitment Reimbursement Retention Retirement Safety Satisfaction Skill Skilled Skills Social Society Stakeholder Supplier Supply Chain Training Union Volunteer Women Workers Workforce Workplace Safety Anti-corruption Assessment Assurance Attorneys General Audit Bonus Bribe Bribery Chronic Classified Classified Board Commitment Conflict of Interest Corporate Governance Corporate Purpose Corruption Department of ESG Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Incentivize Independence Independent Innovate Innovation Innovative Investigation Lawsuit Leadership Litigation Long-term Majority Mission Oversee Oversight Plaintiff Pledging Poison Pill Purpose Quality Standard R&D Reputation Reputational Research and Development Responsibility Responsible Special Meeting Strategy Sustainable Targets Tax Transparency

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

The 2021 Annual Meeting of Stockholders (the “Annual Meeting”) of scPharmaceuticals Inc. (the “Company”) was held on June 8, 2021. Proxies were solicited pursuant to the Company’s proxy statement filed on April 27, 2021 with the Securities and Exchange Commission under Section 14(a) of the Securities Exchange Act of 1934, as amended. The number of shares of the Company’s common stock, $0.0001 par value per share (“Common Stock”), entitled to vote at the Annual Meeting was 27,355,453. The number of shares of Common Stock present or represented by valid proxy at the Annual Meeting was 16,438,766, representing 60.09% of the total number of shares of Common Stock entitled to vote at the Annual Meeting. Each share of Common Stock was entitled to one vote with respect to matters submitted to the Company’s stockholders at the Annual Meeting.
At the Annual Meeting, the Company’s stockholders were asked (i) to elect three Class I directors to the Company’s Board of Directors (the “Board”), each to hold office until the 2024 annual meeting of stockholders and until his or her successor is duly elected and qualified, or until his or her earlier resignation or removal, and (ii) to ratify the appointment of RSM US LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021.
The voting results reported below are final.
Proposal 1 – Election of Directors
Frederick Hudson, Leonard D. Schaeffer and Sara Bonstein were duly elected to the Company’s Board as Class I directors. The results of the election were as follows:

NOMINEE

Frederick Hudson	13,492,848	95.96	%	567,398	4.04	%	2,378,520
Leonard D. Schaeffer	13,483,500	95.90	%	576,746	4.10	%	2,378,520
Sara Bonstein	14,031,185	99.79	%	29,061	0.21	%	2,378,520

Proposal 2 – Ratify the Appointment of Independent Registered Public Accounting Firm
The appointment of RSM US LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021 was ratified. The results of the ratification were as follows:


	FOR			AGAINST			ABSTAIN
NUMBER		16,414,616			23,432			718
PERCENTAGE OF VOTED		99.86	%		0.14	%		—